Reading time is <1 mins
.
.
DRUG PATIENTS USED WITH CORONA IS BEING DISCUSSED
World scientists also began questioning the drug Favipiravir after a year of hydroxychloroquine given to Covid-19 patients. Member of the Working Group on the pandemic of the Turkish Medical Association (TTB) said that because he used the drug Favipiravir, patients whose liver tests were impaired and had serious side effects were seen.
After hydroxychloroquine used in Covid-19 patients, Favipiravir was also the subject of discussion, although the World Health Organization advised against use and TTB and specialty associations warned for 12 months. Pandemic Working Group Member Prof. Dr. said that there is confusion in the literature about Favipiravir, which is frequently used in the world.
“We see patients whose liver tests are impaired and who have serious side effects because they use this drug in practice,” was said. So when we look at the new guide in this sense, there is a definition that should be used in patients over the age of 50 and with other diseases. We can accept this as a sign that confidence in the drug used is low,” was said.
.
AND BEWARE OF BLOOD THINNERS
Another problem is related to blood thinners, Prof. Dr. said, “it is very unnecessary and is used very widely in patients who do not need it. Both drugs that prevent clotting in the artery and drugs that prevent clotting in the veins are used together. As a result, serious bleeding occurs in patients, which causes them to die unexpectedly, where they stand,” he said, noting that they received these messages from many places.
.
IT SHOULD BE APPLIED IN THE HOSPITAL
“If the treatment is necessary, these treatments should not be recommended to Covid-19 patients at home. Or, when patients are discharged, if the doctor deems it appropriate, the dose and duration applied should be determined by the Turkish doctor and recommended,” he said.
.
.
.